What the Evidence Suggests (So Far) Tendon & musculoskeletal: In vitro work shows BPC-157 can increase growth-hormone receptor expression in tendon fibroblasts, consistent with tissue repair pathways
Skin thats not just smoother on the surface, but stronger from within
[3] [2] Where there is neurological involvement, the loading phase uses alternate-day injections until there is no further improvement, and maintenance is 1 mg every two months
If you're on injection and still not responding, your prescribing clinician may consider a switch from semaglutide to tirzepatide or a dual-compound approach like GLP-Squared
Unlike GLP-1 medications, its effects are not fast-acting and havent been studied long-term in large groups
It issued a profit warning last week and its Q2 earnings report issued today showed the damage: combined Ozempic and Wegovy sales rose 16% for the period, a significant slowdown as NVOs total sales missed estimates